1. Search Result
Search Result
Results for "

APV

" in MedChemExpress (MCE) Product Catalog:

10

Inhibitors & Agonists

1

Inhibitory Antibodies

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-100714A
    D-AP5
    Maximum Cited Publications
    29 Publications Verification

    D-APV; D-2-Amino-5-phosphonovaleric acid

    iGluR Neurological Disease
    D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors .
    D-AP5
  • HY-100714
    DL-AP5
    3 Publications Verification

    2-APV; DL-2-Amino-5-phosphonovaleric acid

    iGluR Neurological Disease Inflammation/Immunology
    DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina .
    DL-AP5
  • HY-100714C
    DL-AP5 sodium
    3 Publications Verification

    2-APV sodium; DL-2-Amino-5-phosphonovaleric acid sodium

    iGluR Neurological Disease Inflammation/Immunology
    DL-AP5 (2-APV) sodium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 sodium shows significantly antinociceptive activity. DL-AP5 sodium specifically blocks on channels in the rabbit retina .
    DL-AP5 sodium
  • HY-W073501

    trans-2-Pentenedioic acid

    Drug Isomer Endogenous Metabolite Cardiovascular Disease Metabolic Disease
    trans-Glutaconic acid (trans-2-Pentenedioic acid) is the trans isomer of Glutaconic acid (HY-W073501A). trans-Glutaconic acid is a neurotoxic metabolite. trans-Glutaconic acid induces weak neurotoxicity in cultured cerebral neocortical neurons. trans-Glutaconic acid elicits significant electrophysiological responses in rat neocortical wedge preparations at high concentrations. trans-Glutaconic acid can be used in studies related to glutaric acidemia type 1 .
    trans-Glutaconic acid
  • HY-P991095

    APV-527; ATOR-1016

    Transmembrane Glycoprotein Cancer
    ALG.APV-527 (APV-527) is a bispecific 4-1BB (CD137) and 5T4 antibody. ALG.APV-527 is designed to activate 4-1BB on T and natural killer (NK) cells only when simultaneously bound to 5T4-expressing tumor cells. ALG.APV-527 has a potent antitumor activity .
    ALG.APV-527
  • HY-100714D

    2-APV lithium; DL-2-Amino-5-phosphonovaleric acid lithium

    iGluR Neurological Disease Inflammation/Immunology
    DL-AP5 (2-APV) lithium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 lithium shows significantly antinociceptive activity. DL-AP5 lithium specifically blocks on channels in the rabbit retina .
    DL-AP5 lithium
  • HY-100714R

    2-APV (Standard); DL-2-Amino-5-phosphonovaleric acid (Standard)

    Reference Standards iGluR Neurological Disease Inflammation/Immunology
    DL-AP5 (Standard) is the analytical standard of DL-AP5. This product is intended for research and analytical applications. DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 shows significantly antinociceptive activity. DL-AP5 specifically blocks on channels in the rabbit retina .
    DL-AP5 (Standard)
  • HY-100714CR

    2-APV sodium (Standard); DL-2-Amino-5-phosphonovaleric acid sodium (Standard)

    Reference Standards iGluR Neurological Disease Inflammation/Immunology
    DL-AP5 (sodium) (Standard) is the analytical standard of DL-AP5 (sodium). This product is intended for research and analytical applications. DL-AP5 (2-APV) sodium is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist. DL-AP5 sodium shows significantly antinociceptive activity. DL-AP5 sodium specifically blocks on channels in the rabbit retina .
    DL-AP5 sodium (Standard)
  • HY-100714B

    L-APV; L-2-Amino-5-phosphonovaleric acid

    iGluR Neurological Disease
    L-AP5 (L-APV; L-2-Amino-5-phosphonovaleric acid) is an NMDA antagonist and is the isomer of D-AP5 (HY-100714A). L-AP5 shows a relatively weak amino acid and synaptic blocking activity .
    L-AP5
  • HY-100714AR

    D-APV (Standard); D-2-Amino-5-phosphonovaleric acid (Standard)

    iGluR Reference Standards Neurological Disease
    D-AP5 (Standard) is the analytical standard of D-AP5 (HY-100714A). This product is intended for research and analytical applications. D-AP5 (D-APV) is a selective and competitive NMDA receptor antagonist with a Kd of 1.4 μM. D-AP5 (D-APV) inhibits the glutamate binding site of NMDA receptors .
    D-AP5 (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: